Compare RNW & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNW | NVCR |
|---|---|---|
| Founded | 2011 | 2000 |
| Country | United Kingdom | Switzerland |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.0B |
| IPO Year | 2021 | 2015 |
| Metric | RNW | NVCR |
|---|---|---|
| Price | $6.83 | $16.15 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $7.00 | ★ $28.08 |
| AVG Volume (30 Days) | ★ 2.6M | 1.1M |
| Earning Date | 06-15-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 21.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $655,353,000.00 |
| Revenue This Year | N/A | $7.72 |
| Revenue Next Year | $11.50 | $6.74 |
| P/E Ratio | $14.63 | ★ N/A |
| Revenue Growth | N/A | ★ 8.28 |
| 52 Week Low | $4.39 | $9.82 |
| 52 Week High | $8.24 | $21.45 |
| Indicator | RNW | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 63.25 | 45.15 |
| Support Level | $6.78 | $14.84 |
| Resistance Level | $6.85 | $18.43 |
| Average True Range (ATR) | 0.03 | 0.80 |
| MACD | -0.02 | -0.27 |
| Stochastic Oscillator | 50.00 | 32.09 |
ReNew Energy Global PLC is a developer and operator of clean energy projects. Additionally, it provides clean energy solutions and value-added energy offerings through digitalization, storage, and carbon market services that are increasingly integral to addressing climate change. The company has two reportable segments: Generation and sale of renewable power and Manufacturing of power equipment. The majority of its revenue is generated from the Generation and sale of renewable power segment, which reflects the revenue earned from its utility-scale wind energy projects, solar energy projects, and hydro energy projects. The Manufacturing of power equipment segment relates to the manufacturing of solar panels and modules. Geographically, all of its material revenues are generated from India.
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.